Atlas Trials

Orphalan

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Orphalan

RecordFirmDate
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients. (NCT07465718)Orphalan2026-08-01
Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride (NCT07010575)Orphalan2025-07-15
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily). (NCT06128954)Orphalan2024-01-16
Real World Evidence Study in Subjects With Wilson's Disease (NCT05783687)Orphalan2023-06-28
International Wilson's Disease Patient Registry (iWilson Registry) (NCT05239858)Orphalan2022-06-29
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease (NCT03539952)Orphalan2018-09-03

Track Orphalan automatically

Every clearance here is in the API, with alerts when new ones post.